Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

30 56 30 30 13 4 7 15 13 20 25 12 35 13 2

Research, Review articles and Editorials

0 6 2 4 1 1 6 14 12 17 25 12 34 7 2

Research communications, Review communications, Editorial communications, Case reports and Commentary

30 50 28 8 2 0 1 1 1 2 0 0 0 0 0

Conference proceedings

0 0 0 0 0 0 35 102 83 47 82 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

35 55 58 71 61 49 63 48 72 63 23 8 6 0 0
Journal total citations count 613
Journal impact factor 2.31
Journal 5 years impact factor 3.74
Journal cite score 4.86
Journal h-index 12
Important citations

Clinical relevance of efavirenz pharmacokinetics and pharmacogenetics in HIV/AIDS therapy

Genetic polymorphism of glutathione S-transferases: Relevance to neurological disorders

Pharmacogenomics of drug metabolizing enzymes and transporters: relevance to precision medicine

Velký význam malých nekódujících RNA pro lidský organismus

Trends of non-coding RNAs research in acute rejection after kidney transplantation

RNA as a Drug Target and its Tools and Databases

P?ehled malých nekódujících RNA

miR-185-5p response to usnic acid suppresses proliferation and regulating apoptosis in breast cancer cell by targeting Bcl2

InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment

Extracellular RNA in viral–host interactions: Thinking outside the cell

Small non-coding RNAs as regulators of structural evolution and carcinogenesis

Inferring and analyzing module-specific lncRNA–mRNA causal regulatory networks in human cancer

Particularit??ile farmacodinamice, farmacogenetice ?i farmacocinetice ale carvedilolului

???????????????? ?????????? ? ????????????? ???????

Pharmacogenomics of Hypertension Treatment

????? ?????? ?? ??????????????? ? ???????? ???????????? ?????????? ? ??????? ?? ????????????? ??????????

??????????? ???????????? ??????????: ??????????? ??????????????? ? ???????????????

??????????????? ???????????? ??????????: ??????????? ??????????????? ??????????

??????????????? ???????????? ??????????: ??????????? ??????????????? ??????????

The role of pharmacogenomics in adverse drug reactions